'Emerging' Biomarker May Predict MCI Years Before Symptoms

Measuring levels of synaptic protein NPTX2 in cognitively normal adults may help predict onset of mild cognitive impairment years before symptoms emerge.
Medscape Medical News

source https://www.medscape.com/viewarticle/995265?src=rss